NASDAQ:OVID
Ovid Therapeutics Inc Stock Insider Trading
$3.06
-0.0100 (-0.326%)
At Close: May 03, 2024
Date | Action | Amount | Person | Type |
---|---|---|---|---|
Mar 18, 2024 | Buy | 18 248 | Levin Jeremy M | Common Stock |
Feb 22, 2024 | Buy | 168 750 | Tardio Jason | Stock Option (Right to Buy) |
Feb 22, 2024 | Buy | 28 125 | Tardio Jason | Common Stock |
Feb 22, 2024 | Buy | 28 125 | Rona Jeffrey A | Common Stock |
Feb 22, 2024 | Buy | 168 750 | Rona Jeffrey A | Stock Option (Right to Buy) |
Feb 22, 2024 | Buy | 30 000 | Poole Robert Michael | Stock Option (Right to Buy) |
Feb 22, 2024 | Buy | 168 750 | Perone Thomas Michael | Stock Option (Right to Buy) |
Feb 22, 2024 | Buy | 28 125 | Perone Thomas Michael | Common Stock |
Feb 22, 2024 | Buy | 700 000 | Levin Jeremy M | Stock Option (Right to Buy) |
Feb 22, 2024 | Buy | 30 000 | Friedman Bart | Stock Option (Right to Buy) |
Feb 22, 2024 | Buy | 30 000 | Fitzgerald Kevin Joseph | Stock Option (Right to Buy) |
Feb 22, 2024 | Buy | 30 000 | Duncan Barbara Gayle | Stock Option (Right to Buy) |
Feb 22, 2024 | Buy | 30 000 | Bernstein Karen | Stock Option (Right to Buy) |
Dec 04, 2023 | Sell | 573 275 | Levin Jeremy M | Common Stock |
Dec 04, 2023 | Sell | 573 275 | Levin Jeremy M | Common Stock |
Feb 23, 2023 | Buy | 175 000 | Tardio Jason | Stock Option (Right to Buy) |
Feb 23, 2023 | Buy | 175 000 | Rona Jeffrey A | Stock Option (Right to Buy) |
Feb 23, 2023 | Buy | 15 000 | Poole Robert Michael | Stock Option (Right to Buy) |
Feb 23, 2023 | Buy | 175 000 | Perone Thomas Michael | Stock Option (Right to Buy) |
Feb 23, 2023 | Buy | 600 000 | Levin Jeremy M | Stock Option (Right to Buy) |
Feb 23, 2023 | Buy | 15 000 | Friedman Bart | Stock Option (Right to Buy) |
Feb 23, 2023 | Buy | 15 000 | Fitzgerald Kevin Joseph | Stock Option (Right to Buy) |
Feb 23, 2023 | Buy | 15 000 | Duncan Barbara Gayle | Stock Option (Right to Buy) |
Feb 23, 2023 | Buy | 15 000 | Bernstein Karen | Stock Option (Right to Buy) |
Sep 12, 2022 | Sell | 17 344 | Tardio Jason | Common Stock |
Jul 01, 2022 | Buy | 5 750 000 | Takeda Pharmaceutical Co Ltd | Common Stock |
Jul 01, 2022 | Buy | 1 250 | Takeda Pharmaceuticals U.s.a., Inc. | Series A Convertible Preferred Stock |
Jul 01, 2022 | Buy | 1 250 | Takeda Pharmaceutical Co Ltd | Series A Convertible Preferred Stock |
Jul 01, 2022 | Buy | 1 250 | Takeda Pharmaceuticals U.s.a., Inc. | Series A Convertible Preferred Stock |
Jul 01, 2022 | Sell | 5 750 000 | Takeda Pharmaceutical Co Ltd | Common Stock |
Jul 01, 2022 | Sell | 1 250 | Takeda Pharmaceutical Co Ltd | Series A Convertible Preferred Stock |
Apr 08, 2022 | Buy | 69 424 | Friedman Bart | Stock Option (Right to Buy) |
Apr 08, 2022 | Buy | 87 498 | Tardio Jason | Stock Option (Right to Buy) |
Apr 08, 2022 | Buy | 10 000 | Tardio Jason | Stock Option (Right to Buy) |
Apr 08, 2022 | Buy | 10 000 | Tardio Jason | Stock Option (Right to Buy) |
Apr 08, 2022 | Buy | 423 244 | Levin Jeremy M | Stock Option (Right to Buy) |
Apr 08, 2022 | Buy | 194 399 | Rona Jeffrey A | Stock Option (Right to Buy) |
Apr 08, 2022 | Buy | 194 399 | Rona Jeffrey A | Stock Option (Right to Buy) |
Apr 08, 2022 | Buy | 10 000 | Rona Jeffrey A | Stock Option (Right to Buy) |
Apr 08, 2022 | Buy | 25 399 | Perone Thomas Michael | Stock Option (Right to Buy) |
Apr 08, 2022 | Buy | 10 000 | Perone Thomas Michael | Stock Option (Right to Buy) |
Apr 08, 2022 | Buy | 10 000 | Perone Thomas Michael | Stock Option (Right to Buy) |
Apr 08, 2022 | Buy | 21 347 | Duncan Barbara Gayle | Stock Option (Right to Buy) |
Apr 08, 2022 | Buy | 69 424 | Bernstein Karen | Stock Option (right to buy) |
Feb 03, 2022 | Buy | 15 000 | Poole Robert Michael | Stock Option (Right to Buy) |
Feb 03, 2022 | Buy | 15 000 | Friedman Bart | Stock Option (Right to Buy) |
Feb 03, 2022 | Buy | 15 000 | Fitzgerald Kevin Joseph | Stock Option (Right to Buy) |
Feb 03, 2022 | Buy | 15 000 | Duncan Barbara Gayle | Stock Option (Right to Buy) |
Feb 03, 2022 | Buy | 15 000 | Bernstein Karen | Stock Option (Right to Buy) |
Feb 03, 2022 | Buy | 175 000 | Tardio Jason | Stock Option (Right to Buy) |
Feb 03, 2022 | Buy | 218 750 | Rona Jeffrey A | Stock Option (Right to Buy) |
Feb 03, 2022 | Buy | 175 000 | Perone Thomas Michael | Stock Option (Right to Buy) |
Feb 03, 2022 | Buy | 600 000 | Levin Jeremy M | Stock Option (Right to Buy) |
Oct 06, 2021 | Buy | 30 000 | Fitzgerald Kevin Joseph | Stock Option (Right to Buy) |
Oct 06, 2021 | Buy | 0 | Fitzgerald Kevin Joseph | |
Jul 14, 2021 | Buy | 34 017 | Rakhit Amit | Common Stock |
Jul 14, 2021 | Sell | 34 017 | Rakhit Amit | Common Stock |
Jul 14, 2021 | Buy | 34 017 | Rakhit Amit | Stock Option (Right to Buy) |
Jul 09, 2021 | Buy | 30 000 | Poole Robert Michael | Stock Option (Right to Buy) |
Jul 09, 2021 | Buy | 0 | Poole Robert Michael | |
Jul 01, 2021 | Buy | 50 000 | Tardio Jason | Stock Option (Right to Buy) |
Jun 11, 2021 | Buy | 15 000 | Duncan Barbara Gayle | Stock Option (Right to Buy) |
Jun 11, 2021 | Buy | 15 000 | Friedman Bart | Stock Option (Right to Buy) |
Jun 11, 2021 | Buy | 15 000 | Bernstein Karen | Stock Option (Right to Buy) |
Jun 02, 2021 | Buy | 100 000 | Rona Jeffrey A | Stock Option (Right to Buy) |
May 17, 2021 | Buy | 1 750 | Williams Douglas E | Stock Option (Right to Buy) |
May 17, 2021 | Buy | 1 750 | Friedman Bart | Stock Option (Right to Buy) |
May 17, 2021 | Buy | 1 750 | Duncan Barbara Gayle | Stock Option (Right to Buy) |
May 17, 2021 | Buy | 1 750 | Bernstein Karen | Stock Option (Right to Buy) |
Feb 05, 2021 | Buy | 75 000 | Tardio Jason | Stock Option (Right to Buy) |
Dec 17, 2020 | Buy | 175 000 | Tardio Jason | Stock Option (Right to Buy) |
Dec 17, 2020 | Buy | 175 000 | Perone Thomas Michael | Stock Option (Right to Buy) |
Dec 17, 2020 | Buy | 175 000 | Rona Jeffrey A | Stock Option (Right to Buy) |
Dec 17, 2020 | Buy | 200 000 | Rakhit Amit | Stock Option (Right to Buy) |
Dec 17, 2020 | Buy | 650 000 | Levin Jeremy M | Stock Option (Right to Buy) |
Dec 17, 2020 | Buy | 100 000 | Haasner Dirk | Stock Option (Right to Buy) |
Dec 17, 2020 | Buy | 125 000 | Daly Timothy | Stock Option (Right to Buy) |
Nov 25, 2020 | Buy | 44 000 | Perone Thomas Michael | Stock Option (Right to Buy) |
Nov 25, 2020 | Buy | 44 000 | Tardio Jason | Stock Option (Right to Buy) |
Oct 11, 2020 | Buy | 20 000 | Rona Jeffrey A | Stock Option (Right to Buy) |
Oct 11, 2020 | Buy | 20 000 | Haasner Dirk | Stock option (Right to Buy) |
Oct 11, 2020 | Buy | 20 000 | Perone Thomas Michael | Stock Option (Right to Buy) |
Sep 30, 2020 | Buy | 325 000 | Rona Jeffrey A | Stock Option (Right to Buy) |
Sep 30, 2020 | Buy | 0 | Rona Jeffrey A | |
Aug 28, 2020 | Buy | 8 488 | Levin Jeremy M | Common Stock |
Jun 19, 2020 | Buy | 50 000 | Tardio Jason | Stock Option (Right to Buy) |
Jun 05, 2020 | Buy | 13 250 | Williams Douglas E | Stock Option (Right to Buy) |
Jun 05, 2020 | Buy | 13 250 | Friedman Bart | Stock Option (Right to Buy) |
Jun 05, 2020 | Buy | 13 250 | Duncan Barbara Gayle | Stock Option (Right to Buy) |
Jun 05, 2020 | Buy | 13 250 | Bernstein Karen | Stock Option (Right to Buy) |
Jan 01, 2020 | Buy | 75 000 | Perone Thomas Michael | Stock Option (Right to Buy) |
Dec 18, 2019 | Buy | 200 000 | Rakhit Amit | Stock Option (Right to Buy) |
Dec 18, 2019 | Buy | 600 000 | Levin Jeremy M | Stock Option (Right to Buy) |
Dec 18, 2019 | Buy | 100 000 | Haasner Dirk | Stock Option (Right to Buy) |
Dec 18, 2019 | Buy | 125 000 | Daly Timothy | Stock Option (Right to Buy) |
Dec 18, 2019 | Buy | 100 000 | Perone Thomas Michael | Stock Option (Right to Buy) |
Oct 08, 2019 | Buy | 2 000 000 | Takeda Pharmaceutical Co Ltd | Common Stock |
Sep 20, 2019 | Sell | 465 116 | Levin Jeremy M | Common Stock |
Feb 22, 2019 | Buy | 0 | Takeda Pharmaceutical Co Ltd | Common Stock |
Feb 22, 2019 | Buy | 0 | Takeda Pharmaceutical Co Ltd | Common Stock |
INSIDER POWER |
---|
21.637 |
Last 100 transactions |
Buy: 16 581 029 | Sell: 7 414 277 (Shares) |
Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 21.637.
In total, the insiders bought 16 581 029 and sold 7 414 277 OVID shares in the last 100 trades.